Bain Capital Life Sciences Investors, LLC
Position in CCCC — C4 Therapeutics, Inc.
CIK 1703031
Boston, MA
Position in CCCC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,492,819
+$14,630,696 QoQ
Shares Held
7,171,910
0.0% QoQ
Ownership
5.83%
of shares outstanding
% of Portfolio
1.99%
of 13F equity value
Holder Rank
#6
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bain Capital Life Sciences Investors, LLC holds $1,318,022,438 across 17 Biotechnology names. CCCC ranks #11 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KLRA |
Kailera Therapeutics, Inc.
|
22,583,268 | $497,509,394 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
3,906,565 | $131,141,499 | |
| 3 | SVRA |
Savara Inc
|
17,600,621 | $108,419,825 | |
| 4 | SLDB |
Solid Biosciences Inc.
|
9,808,819 | $97,990,101 | |
| 5 | PHVS |
Pharvaris N.V.
|
2,675,509 | $92,519,101 | |
| 6 | OLMA |
Olema Pharmaceuticals, Inc.
|
7,085,249 | $88,636,464 | |
| 7 | COAG |
Hemab Therapeutics Holdings, Inc.
|
1,650,000 | $60,604,500 | |
| 8 | CABA |
Cabaletta Bio, Inc.
|
17,241,445 | $53,620,893 |
All Filings in CCCC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,492,819 | 7,171,910 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,862,123 | 7,171,910 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,698,348 | 7,171,910 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,468,440 | 1,111,910 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,590,031 | 1,111,910 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,779,056 | 1,111,910 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,002,876 | 1,111,910 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,337,887 | 1,111,910 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,137,024 | 1,111,910 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,331,855 | 1,142,210 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,278,486 | 1,642,210 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,054,510 | 1,642,210 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,516,077 | 1,642,210 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,156,539 | 1,642,210 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,689,039 | 1,642,210 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,402,181 | 1,642,210 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,382,263 | 1,642,210 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $39,840,014 | 1,642,210 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $52,879,162 | 1,642,210 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $73,373,898 | 1,642,209 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $62,141,188 | 1,642,209 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $60,745,310 | 1,642,209 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $54,406,384 | 1,642,209 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||